The prevalence of birth in the home setting varies considerably globally. The concepts of ‘too little too late’ and ‘too much too soon’ can be usefully applied to consider the impact of home birth prevalence in both low- and high-income countries. While in many parts of the world, home birth is associated with high maternal mortality rates, locally, the institutionalisation of birth in the hospital setting can be considered a pertinent factor when examining increasing rates of medical intervention. Home birth is a human right in European countries and can have a multitude of benefits, including a reduced likelihood of intervention for low-risk families, and as such should be an option available to birthing people.

EuroKhat: A pilot study on Khat consumption among Yemeni migrants in Germany.

Many patients with prostate cancer receive moderately hypo-fractionated radiotherapy (mHF-RT). Inappropriate bladder filling during the mHF-RT course increases urinary toxicity. This study investigated the impact of pre-RT bladder volumes on the subsequent filling status. One-hundred-and-nineteen prostate cancer patients irradiated with mHF-RT (60 Gy in 20 fractions) were included in this retrospective study from three European countries. The impact of pre-RT bladder volumes on the number of fractions with a volume <200 ml was examined. In case of a pre-RT bladder volume <200, <250, and <300 ml, the corresponding mean number of fractions with a bladder volume <200 ml during mHF-RT was 16.6 (±5.0), 15.9 (±5.6), and 15.1 (±5.9), respectively. The impact of the pre-RT volume (<200 vs. ≥200 ml, <250 vs. ≥250, <300 vs. ≥300 ml) on the number of fractions with a volume <200 ml was always highly significant (p<0.0001). Pre-RT bladder volumes <200 ml, <250 ml, and <300 ml were significantly associated with higher numbers of bladder volumes <200 ml during mHF-RT. These findings will lead to an amendment to a prospective trial.

The Whole School Food Approach: A European framework and implementation to promote healthy and sustainable school food systems.

Corporate social responsibility and earning management: evidence from European countries

Longitudinal monitoring of global prevalence, genomic characterization and transmission routes of Salmonella Derby strains from food, humans and the environment.

Fibrodysplasia Ossificans Progressiva (FOP) is a rare and debilitating genetic disorder characterized by the progressive formation of bone in muscles and connective tissues. This scientometric analysis examines the global research trends on FOP between 1989 and 2023 using bibliographic data from Web of Science. The study highlights key patterns in publication productivity, influential journals, institutions, and the geographical distribution of research. The findings reveal that the United States leads both in terms of total publications and citation impact, with significant contributions from the UK, Italy, Japan, and other European countries. Additionally, the analysis identifies the major document types, including articles and reviews, and evaluates the collaborative efforts across institutions. The study offers valuable insights into the global research landscape of FOP, providing a foundation for future studies and international collaborations.

The current status of neonatal echovirus 11 infections in Japan: A comparison to the global situation.

Application of International Reference Pricing Rules to Forecast Pharmaceutical Launch Prices in 5 European Countries.

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.

An AI-based microsimulation for predicting health outcomes among people experiencing homelessness.

Epidemiological and microbiological characteristics of endogenous endophthalmitis (EE) can vary by population and geographical area, with different risk factors. This study from a tertiary care centre aimed to provide additional data from one European country in the field of EE. This retrospective study was conducted on patients diagnosed with EE at the University Hospital of Grenoble-Alpes, France, between 2014 and 2023. General and ocular clinical data, along with microbiological findings, were collected at baseline and on follow-up. Thirty-three patients were diagnosed with EE in this study with a mean age of 70 ± 17.7 years, and 51.5% were male. Most cases were unilateral. Common health conditions included cancer, and diabetes mellitus, with endocarditis being the leading source of infection. Baseline visual acuity ranged from 20/20 to no light perception. Blood cultures were positive in 87.8% of the cases. Gram-positive bacteria, especially Staphylococcus aureus, were the most common pathogens, followed by Candida albicans. Pars plana vitrectomy was performed in 33% of the patients. At the end of the follow-up, four patients had lost vision, two developed phthisis, and mortality was reported in 24% of the patients. This study on endogenous endophthalmitis highlights that, in Europe, the primary risk factors are cancer and diabetes, with endocarditis being the most common source of infection. According to our findings, Gram-positive bacteria, particularly Streptococcus species and Staphylococcus aureus, are the most frequently identified pathogens in Europe. These findings differ significantly from reports originating from the USA and Asia.

Unveiling the energy price tag - Assessing the burden of household energy expenditures among European countries

Current situation of solid organ transplantation from HIV-positive donors to HIV-positive recipients in Europe: the Spanish perspective.

Even though the use of biosimilar medicines is increasing across European countries, detailed and regularly published official data on biosimilar uptake are not publicly available except in Italy and Portugal. The main objective of this study was to provide a nationwide assessment of biosimilar consumption and uptake patterns in Spain between 2016 and 2023. Data were provided by the Ministry of Health and included the defined daily dose (DDD) of biosimilars (N=17) dispensed through both community pharmacies and public hospitals, biosimilar market share, and information on the registration status of both the bio-originator and biosimilars of each active principle. Data were analysed using non-parametric tests and bootstrap analysis with 10,000 replications, considering market share, time since market entry, number of competitors, and indication type (acute vs. chronic). The results show that biosimilar penetration increased from 9% in 2016 to 47% in 2023. In 2023, the biosimilar market share was substantially higher in the hospital setting (68%) compared to community pharmacies (34%). Biosimilars indicated for acute conditions achieved significantly higher market shares than those used for chronic conditions (p < 0.05). A positive correlation was observed between market share and the number of competitors, which was statistically significant only in the hospital setting (p = 0.007), while no significant association was found in the community pharmacy setting. Additionally, no correlation was identified between biosimilar market penetration and the time elapsed since the introduction of the first biosimilar. Other factors, such as prices, tendering, interchangeability, patients' characteristics, etc., may also influence biosimilar use. We suggest further analysis of policies aimed at promoting biosimilar adoption in Spain.

Exploring the productivity per unit of livestock, land and labour of organic multi-species livestock farms in six European countries

Alcohol-impaired driving in Tunisia: Forensic insights and population-level data for North African public health and road safety.

Approval of transport infrastructure projects and systemic differences in EIA approaches: A comparative study of two central European countries

Food insecurity and multidimensional healthy aging across 31 countries: pooled longitudinal evidence from four cohorts.

The impact of economic inequality on fiscal multipliers: do Central and Eastern European countries stand out